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Radionuclide Assessment of Left Ventricular Diastolic Filling in 
Diabetes Mellitus With and Without Cardiac Autonomic Neuropathy 
JOEL K. KAHN, MD, BENJAMIN ZOLA, MD, JACK E. JUN!, MD, AARON I. VINIK, MD 
Ann Arbor, Michigan 
Indexes of left ventricular diastolic filling were measured 
by radionuclide ventriculography in 28 patients with in-
sulin-dependent diabetes mellitus without evidence of 
ischemic heart disease. Six patients (21 %) had abnormal 
diastolic filling and differed from diabetic patients with 
normal filling in their greater severity of cardiac auto-
nomic neuropathy, assessed by noninvasive means, and 
their lower plasma norepinephrine levels in the supine 
(131.1 ± 24.7 versus 356.2 ± 58.4 pg/ml, p < 0.01) 
and upright (224.9 ± 47.8 versus 673.3 ± 122.3 pg/ml, 
p < 0.005) positions. 
The diabetic patients determined as having cardiac 
autonomic neuropathy (n = 15) had depressed left ven-
tricular diastolic filling compared with subjects free of 
The syndrome of congestive heart failure occurs with in-
creased frequency in patients with diabetes mellitus and 
contributes significantly to their increased cardiovascular 
mortality (1,2). Diabetic patients without evidence of isch-
emic, hypertensive or valvular heart disease may still de-
velop cardiac dysfunction and congestive heart failure (2-9). 
Investigators (5,6) have used radionuclide ventriculography 
to detect abnormalities in left ventricular systolic perform-
ance among diabetic patients without clinical evidence of 
heart disease. Recently, several groups have reported on 
large numbers of patients with the clinical syndrome of 
congestive heart failure who were found to have normal 
systolic function by radionuclide techniques (10.11), and a 
greater awareness of the role of disturbed diastolic filling 
in producing the syndrome of congestive heart failure has 
evolved (11). Echocardiographic studies in diabetic patients 
free of clinical evidence of heart disease (7-9) have shown 
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autonomic neuropathy, whether measured as the time 
to peak filling rate (154.2 ± 12.0 versus 119.1 ± 10.6 
ms, p < 0.05) or the time to peak filling rate normalized 
to the cardiac cycle length (24.3 ± 2.2 versus 16.2 ± 
1.5%, P < 0.01). Of the various tests of autonomic ner-
vous system function, the strongest correlate of impaired 
diastolic filling was orthostasis, measured as the decrease 
in systolic blood pressure with standing (r = 0.584, 
P < 0.001). Thus, in patients with diabetes mellitus, 
alterations in sympathetic nervous system activity are 
associated with abnormalities of left ventricular diastolic 
filling. 
(J Am Coll Cardiol 1986;7:1303-9) 
abnormalities of diastolic relaxation and filling in up to 90% 
of patients. 
We undertook the present investigation to prospectively 
evaluate the characteristics of diastolic filling in patients 
with diabetes mellitus. We utilized computer-assisted anal-
ysis of high temporal resolution time-activity curves from 
gated radionuclide ventriculograms to noninvasively assess 
diastolic filling (12-15). 
Methods 
Patients. Twenty-eight patients were studied (Table I). 
Their age ranged from 19 to 44 years; 18 were women and 
10 were men. The duration of diabetes mellitus for the group 
ranged from 10 to 28 years. Fifteen of the patients were 
determined to have cardiac autonomic neuropathy by the 
tests described later. Approval of the study by the Human 
Use Committee of the University of Michigan Medical Cen-
ter was bbtained in December 1983. 
Entry criteria. Patients were selected who met the fol-
lowing entry criteria: 1) insulin-dependent diabetes mellitus 
for 10 years or more; 2) age 18 to 55 years; 3) no clinical 
evidence or history of hypertension, angina pectoris, myo-
cardial infarction or congenital or valvular heart disease; 4) 
normal electrocardiogram at rest; 5) left ventricular ejection 
0735-1097/86/$3 50 
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Table l. Clinical Feature, of 28 Subjects WIth Diabete, Mellitw, 
DuratIon of Smokmg 
Age (yr) Dlabete, WeIght HeIght HI,tory In,ulIn HgbAI C" 
Case & Sex (yr) (kg) (cm) (pack-yrJ (U/day) (gIlOO ml) (ml/mIn) 
28F 20 67 175 0 32 11.8 85 
2 34M 15 64 170 0 24 9.8 90 
3 40M 16 67 162 40 50 NA 90 
4 46M 10 90 188 0 50 76 140 
5 36F 22 57 168 10 32 II 3 90 
6 35F 24 62 158 20 33 NA 80 
7 45F 10 67 162 0 36 NA 90 
8 25F 13 51 168 0 36 NA 120 
9 22F 21 73 172 0 42 89 85 
10 42F 15 67 162 0 31 53 110 
II 41F 22 58 162 0 42 NA 110 
12 27F 15 66 168 0 28 8.7 115 
13 40F 17 61 165 0 40 9.6 90 
14 30F 19 58 162 18 55 NA 120 
15 35F 28 64 162 0 43 NA 120 
16 33F 25 54 162 0 23 NA 95 
17 19F 12 58 168 0 68 11.1 100 
18 29M 20 61 162 7 39 11.8 80 
19 22M 10 73 180 0 34 8.5 90 
20 2SM 10 74 172 6 46 123 80 
21 40M 12 79 178 0 60 II 5 105 
22 35M 27 84 183 0 80 11.5 125 
23 32F 12 51 172 15 56 9.5 100 
24 28M II 73 172 5 57 9.4 80 
25 29F 22 54 165 8 26 NA 105 
26 43M 20 93 183 20 70 92 125 
27 44F 17 61 165 0 46 NA 85 
28 32F 21 51 165 3 51 8.8 115 
Ccc = creatinine clearance; F = female; HgbA I = nondlalyzable glyco5ylated hemoglobin A I. M = male; 
NA = not available. 
fraction 50% or greater as determined by radionuclide ven-
triculography (see later); 6) normal clinical and electrocar-
diographic response to Bruce protocol exercise treadmill 
testing; 7) normal stress and redistribution tomographic thal-
lium scintigraphy (see later); and 8) creatinine clearance 75 
mllmin or greater and urinary protein excretion 3.0 g/day 
or less. All medications other than insulin were stopped at 
least 24 hours before testing. 
Equilibrium radionuclide ventriculography. Gated 
blood pool scintigraphy was performed with the patient in 
the supine position using the in vivo labeling method with 
25 mCi of technetium-99m pertechnetate. Imaging was ac-
complished using a conventional Anger camera equipped 
with a high sensitivity parallel-hole collimator interfaced to 
a dedicated minicomputer system (MDS A3). The left an-
terior oblique projection that best isolated the left ventricle 
was used. The data were digitized to a 64 X 64 pixel matrix 
for subsequent analysis and the cardiac cycle was formatted 
into 32 frames. Data acquisition was terminated after 300,000 
counts/frame were obtained. 
Left v.entricular and background regions of interest were 
identified and high temporal resolution (19 to 39 ms) time-
activity curves were generated. Cardiac cycles falling out-
side a physician-selected range of acceptable cycle lengths, 
typically 3% of the mean cycle length, were excluded to 
prevent distortion of the time-activity curves by extrasys-
toles or spontaneous variations in heart rate at rest ( 16). The 
left ventricular time-activity curves were reconstructed from 
the first three Fourier harmonics (Fig. I), and the value of 
the peak filling rate was determined by computing the first 
derivative of the filling curve and was expressed in units of 
end-diastolic volumes/s (EDV/s). The time of occurrence 
of the peak filling rate was measured as the time from end-
systole on the volume curve to the time of peak filling and 
was expressed in milliseconds. In 46 healthy subjects, Bonow 
et a\. (12) reported values of peak filling rate as 2.5 EDV/s 
or greater and time to peak filling rate as 180 ms or less. 
Because of the wide variability of heart rate at rest observed 
among diabetic patients (17), the RR interval was averaged 
during radionuclide ventriculography and the time to peak 
filling rate was normalized for the cardiac cycle length and 
was expressed as a percent of the total RR interval. 
Thallium perfusion scintigraphy. Patients were exer-
cised on an upright treadmill using the standard Bruce pro-
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Figure 1. Left ventricular time-activity c\)rve reconstructed from 
the first three Fourier harmonics. The peak filling rate (PFR) and 
the time to peak filling rate (tPFR), in units of end-diastolic vol-
umes/s and milliseconds, respectively, are determined from the 
first derivative of the time-activity curve. 
tocol with continuous 12 lead monitoring. One minute be-
fore termination of exercise, 3 mCi of thallium-201 chloride 
was injected intravenously followed by a saline flush. To-
mographic images were obtained immediately after exercise 
and at 3 hours using a rotating gamma camera. Images were 
acquire~ over 1800 of arc and reconstructed using a con-
volution-backprojection algorithm to yield transv~rs!(, short-
axis and horizontal and vertical long-axis sections. Scans 
were interpreted by two independent nuclear medicine spe-
cialists and were considered normal if there were no fixed 
or reversible perfusion defects. 
Extent of diabf;!tic complications. Diabetic complica-
tions were assessed in each patient using the grading system 
outlined by Shapiro (8). Determination of the degree of 
retinopathy was made by an ipdepehdent ophthalmologist. 
Extent of cardiac autonomic neuropathy. Patients were 
tested for cardiac autonomic neuropathy using five nonin-
vasive indexes of autonomic function (18-20). The response 
to each test of aut0!10mic function was graded as normal or 
abnormal and patiel,1ts were assigned an autonomic function 
score from 0 to 5 based on the total number of abnormal 
tests. A subject was classified as having definite cardiac 
autonomic neuropathy if two or more tests were abnormal 
as suggested by Ewing et al. (19). The screening tests con-
sisted of the follbwing. 
1) Pulse at rest. This was determined by examination 
of an electrocardiographic tracing after the patient had been 
lying supine for 15 minutes, with abnormal defined as 100 
beats/min or more. 
2) Beat to beat heart rate variability. This was deter-
mined with the subject lying quietly and breathing deeply 
at 6 breaths/min. The difference between the minimal and 
maximal heart rate was determined by electrocardiographic 
tracings over I minute, with abnormal defined as 10 beats/min 
or less. 
3) Valsalva maneuver. Subjects blew into a manometer 
to maintain a pressure of 40 mm Hg for 15 seconds during 
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continuous electrocardiographic monitoring. The ratio of the 
longest RR interval after the maneuver to the shortest RR 
interval during the maneuver was calculated; abnormal was 
defined as 1.10 or less. 
4) Heart rate response to standing. During continuous 
electrocardiographic monitoring, the ratio of the longest RR 
interval of the 30th beat after standing compared with the 
RR interval at the 15th beat (30115 ratio) was calculated; 
abnormal was defined as 1.00 or less. 
5) Blood pressure response to standing. The decrease 
in systolic blood pressure after 1 minute of standing was 
determined using cuff sphygmomanometry; abnormal was 
defined as 30 mm Hg or greater. 
Determination of plasma norepinephrine. A poly-
ethylene cannula was placed in an antecubital vein with a 
heparin lock. Blood samples were collected after 30 minutes 
with the sllbject in the supine position, and again 15 minutes 
after standing. Plasma norepinephrine concentration was 
measured in the University of Michigan Diabetes Research 
and Training Center Ligand Core Laboratory by the method 
of Peuler and Johnson (21). 
Statistical methods. Data were entered into the CLINFO 
database of the University of Michigan Clinical Research 
Center and significance was evaluated using Student's t test 
and Wilcoxon rank-sum test where appropriate. Multivariate 
t tests were used where interactions of multiple variables 
were examined and variables excluded because of a priori 
contribution to patient selection. Correlations were tested 
by analysis of fit by the method of least mean squares. A 
Figure 2. Indexes of left ventricular diastolic filling determined 
by radionuclide ventriculography in 28 patients with diabetes mel-
litus. The horizontal bar in the left and center panels indicates 
the established normal limit for healthy subjects (2:2.5 end-dia-
stolic volumes/s and sl80 ms, respectively). Each square rep-
resents the group mean ± SE. 
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Table 2. Indexes of Diastolic Filling in Diabetic Patients With and Without Cardiac Autonomic 
Neuropathy (CAN) 
Diabetic patients 
without CAN (n == 13) 
Diabetic patients with 
CAN (n == 15) 




4.10 ± 0.2 
3,48 ± 0.25 
probability (p) value of less than 0.05 was considered sig-
nificant. Although the data are non-Gaussian, data are ex-
pressed as mean ± SE for ease of observations. 
Results 
Diast9lic filling. The mean value of peak filling rate 
(end-diastolic volumes/s) for the entire group of 28 subjects 
was 3.74 ± 0.20 EDV/s (range 1.90 to 5.25) (Fig. 2). The 
mean time to peak filling rate for the group was 139.2 ± 
8.7 ms (range 80 to 260). The RR interval at rest ranged 
from 530 to 1,320 ms. The mean ratio of time to peak filling 
rate/RR interval expressed as a percent was 20.9 ± 1.6% 
(range 10.6 to 41.3). 
Although both peak filling rate and time to peak filling 
rate for the 28 diabetic subjects as a group were within the 
range of values in healthy control subjects (12), individ-
ually, 6 (21 %) of the 28 diabetic patients had abnormal 
diastolic filling (Fig. 2). Two patients had abnormally low 
peak filling rates, two had prolonged time to peak filling 
and two had abnormalities in both variables of ventricular 
filling. The left ventricular ejection fraction of the 6 diabetic 
patients with abnormal diastolic filling (68.0 ± 2.7%) was 
similar to that of the 22 diabetic patients with normal filling 
(71.2 ± 4.3%). 
Determinants of diastolic filling. The 6 diabetic patients 
with abnormal diastolic filling (Cases 1 to 6, Table 1) did 
not differ from the 22 patients with normal filling with regard 
to age, sex or apparent duration of diabetes. However, five 
of the six diabetic patients with abnormal diastolic filling 
were found to have cardiac autonomic neuropathy, and the 
severity of the neuropathy as reflected by the autonomic test 
score was more profound among the six diabetic patients 
with abnormal diastolic filling than in those patients with 
normal filling (3.00 ± 0.73 versus 1.25 ± 0.28, p < 0.05). 
As a group, the diabetic patients with cardiac autonomic 
neuropathy had depressed diastolic filling compared with 
the diabetic patients without cardiac autonomic neuropathy 
(Table 2). Furthermore, the portion of the entire cardiac 
cycle occupied by rapid diastolic filling was significantly 
increased among the patients with neuropathy (Table 2). 
Time to Peak 
Filling Rate (ms) 
119,1 ± 10,6 
154.2 ± 12.0* 
Time to Peak Filling 
Rate/RR Interval 
(0/0) 
16.2 ± 1.5 
24.3 ± 2.2t 
Correlations with the various indexes of diastolic filling 
were sought among age, duration of diabetes, diabetic com-
plication score and the iqdexes of autonomic dysfunction. 
Although age, duration of diabetes and the diabetic com-
plication score did not correlate (p > 0.1) with any of the 
variables of diastolic filling, there was a significant corre-
lation of the cardiac autonomic function score with both 
time to peak filling rate (r = 0.488, P < 0.01) and time to 
peak filling rate as a percent of the RR interval (r = 0.577, 
P < 0.001) (Fig. 3). Analysis of the individual tests of 
cardiac autonomic neuropathy and the indexes of diastolic 
filling revealed that peak filling rate, time to peak filling 
rate and the time to peak filling rate normalized to the RR 
interval correlated roost strongly with the decrease in sys-
tolic blood pressure with standing (Table 3). 
Figure 3. A, Relation between the autonomic function score and 
time to left ventricular peak filling rate (tPFR) in 28 subjects with 
diabetes mellitus. A significant correlation was seen (r = 0.488, 
P < 0.01, y = 114 + 13.9x). B, Relation between the autonomic 
function score and time to left ventricular peak filling rate nor-
malized to the cardiac cycle length (tPFR/RR) in 28 subjects with 
diabetes mellitus. A significant correlation was seen (r = 0.577, 
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Table 3. CorrelatIOns Between IndlYldual Te~t~ of Cardiac Autonomic Neuropathy and Indexes 
of Diastolic Filling 
Peak Fllhng 
Rate 
Pulse at rest r = +0316 
Beat to beat rate vanabihty r = +0.326 
Valsalva maneuver r = +0181 
30115 ratIo on standing r = +0205 
Orthostatic change r = -0383* 
*p < 0.05; tp < 0.001. 
Norepinephrine levels. Plasma norepinephrine levels 
were significantly lower among the 6 diabetic patients with 
abnormal diastolic filling than among the 22 diabetic patients 
with normal filling in both the supine (131.1 ± 24.7 versus 
356.2 ± 58.4 pg/ml, p < 0.01) and the erect (224.9 ± 
47.8 versus 673.3 ± 122.3 pg/ml, p < 0.005) position. 
The incremental change in norepinephrine level from the 
supine to the standing position was also lower among the 
6 diabetic patients with abnormal ventricular filling com-
pared with the 22 subjects with normal diastolic filling when 
expressed either in absolute values (93.8 ± 11.7 versus 
312.3 ± 37.6 pg/ml, p < 0.01) or as percent change (78.5 
± 6.5 versus 113.7 ± 8.9%, P < 0.05). 
Discussion 
In the present study, we found abnormalities of diastolic 
filling in 6 of 28 patients with insulin-dependent diabetes 
of to to 28 years' duration. Abnormalities of diastolic filling 
were not due to depression of left ventricular systolic per-
formance because only patients with a normal left ventric-
ular ejection fraction were studied. Although age, duration 
of diabetes mellitus, microvascular complications, renal failure 
and diabetic control did not appear to be associated with 
the presence of abnormal diastolic filling, impaired cardiac 
autonomic function was associated with abnormal left ven-
tricular diastolic performance. Abnormalities of diastolic 
filling correlated with the overall severity of cardiac auto-
nomic neuropathy, were most closely related to the degree 
of orthostatic hypotension and were associated with low 
circulating plasma norepinephrine levels. 
Methodologic considerations. We utilized computer 
analysis of high temporal resolution time-activity curves 
from radionuclide ventriculograms to noninvasively assess 
left ventricular diastolic performance (12-16.22.23). 
Radionuclide analysis of diastolic filling in patients with 
coronary artery disease has been shown to be a highly sen-
sitive technique with diastolic abnormalities preceding those 
of systolic performance (12,13.23). Limitations of the tech-
nique, including the need to acquire large numbers of total 
radionuclide counts, the need to construct high temporal 
resolution « 40 ms) time-activity curves, and the relative 
TIme to Peak Time to Peak 
Fllhng Rate Filhng/RR Interval 
r = +0.095 r = + 0.394* 
r = -0.213 r = -0.476* 
r = -0.222 r = -0440* 
r = -0304 r = -0433* 
r = - 0.483* r = +0.584t 
value of the indexes measured without simultaneous intra-
ventricular pressure monitoring (13,24) were appreciated in 
the present study. 
Previous investigators (13,16,24) have discussed the ef-
fect of heart rate on the interpretation of indexes of diastolic 
filling derived from radionuclide ventriculography and have 
cautioned that apparent differences in diastolic filling among 
groups may be due to differences in heart rate alone. Nor-
malization of the time to peak filling rate to the RR interval 
has been suggested as a means of accounting for variable 
heart rates in different patient populations (13). We observed 
a wide range of heart rates at rest among the diabetic patients 
studied, similar to previous observations (17), and normal-
ized the time to peak filling rate to the RR interval in our 
subjects to minimize differences of heart rate at rest among 
subgroups of diabetic patients (Table 2), which increased 
the significance of differences between diabetic patients with 
and without neuropathy. 
Diastolic filling in diabetes. Both animal (25-27) and 
human (4,7-9) studies have demonstrated abnormalities in 
diastolic performance in diabetes mellitus. Regan et al. (4) 
reported on eight diabetic subjects without significant oc-
clusive coronary artery disease or evidence of congestive 
heart failure. At cardiac catheterization all eight had sig-
nificantly elevated left ventricular end-diastolic pressure but 
a diminished left ventricular end-diastolic volume index, 
consistent with decreased ventricular compliance. Sander-
sen et al. (7) examined 23 diabetic patients without evidence 
of heart disease using digitized echocardiography. Seven-
teen had abnormal tracings during diastole. Shapiro (8) re-
ported on 142 diabetic patients who were free of clinical 
heart disease, hypertension or conditions known to influence 
ventricular function. Echocardiography with simultaneous 
electrocardiographic and phonocardiographic tracings was 
performed. Only 12 patients (8%), all with recently diag-
nosed diabetes, had normal diastolic filling. Airaksinen et 
al. (9) recently reported on 36 insulin-dependent diabetic 
patients without clinical or exercise electrocardiographic 
evidence of heart disease. When these patients were studied 
by digitized echocardiography, abnormalities of diastolic 
filling were observed in 53%. 
The frequency of abnormal diastolic filling in the present 
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study is lower than that of the previous studies discussed 
(4,7-9). One explanation for the difference is that we did 
not rely on clinical evidence alone to exclude coronary heart 
disease, as did all prior studies. Abenavoli et al. (28) re-
ported that in a group of 16 diabetic patients judged to be 
free of heart disease by clinical criteria, 58% had abnor-
malities suggesting ischemic heart disease detected on ex-
ercise treadmill testing with thallium perfusion imaging. 
Because ischemic heart disease can profoundly alter dia-
stolic filling (12,13,22), we required normal exercise thal-
lium perfusion scintigrams in our subjects. 
Another explanation for the lower incidence of diastolic 
filling abnormalities in the present study is that all patients 
had documentation of normal systolic performance by radio-
nuclide ventriculography. It has been reported in both nor-
mal subjects and subjects with coronary artery disease that 
ejection fraction and peak filling rate are linearly related 
(13), and therefore abnormalities of diastolic performance 
in subjects with depressed systolic function could be pre-
dicted on that basis alone (13,24). 
Pathogenetic considerations. Both in diabetic animals 
and in humans, abnormalities of diastolic function have been 
observed frequently, but the pathogenesis of these abnor-
malities has not been determined. Sandersen et al. (7) ex-
amined the beat to beat variability in 23 subjects and found 
that although there was diminished variability among the 
diabetic patients compared with control subjects, there was 
no correlation between beat to beat variability and specific 
abnormalities of diastolic filling. Although 19 of the 23 
subjects had retinopathy, no association between the type 
of diastolic filling abnormality and the degree of retinopathy, 
duration of diabetes or quality of diabetic control was found. 
Regan et al. (4) performed right atrial pacing with coronary 
sinus lactate determinations to detect the presence of mi-
crovascular coronary artery disease in eight asymptomatic 
diabetic patients with abnormal ventricular compliance. Ar-
terial concentrations of lactate and the arterial-coronary si-
nus concentrations of lactate were not different from those 
of control patients. In the 142 subjects studied by Shapiro 
(8), a close correlation between cardiac function and mi-
crovascular disease was found. Among the subset of 42 
insulin-dependent diabetic patients, the duration of diabetes 
was related to the peak rate of wall thinning, isovolumic 
relaxation time and the interval from the minimal dimension 
to the opening of the mitral valve. Similarly, Airaksinen et 
al. (9) noted that diastolic performance was depressed most 
severely among diabetic patients with severe microvascular 
disease. Although beat to beat variability was observed to 
be diminished in the diabetic patients compared with control 
subjects, a direct relation between autonomic neuropathy 
and diastolic dysfunction was not examined (9). 
Our study identified an association between autonomic 
nervous system function and cardiac diastolic performance, 
JACC Vol 7, No 6 
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but no similar association between microvascular disease 
and diastolic filling was found, in contrast to other reports 
(8,9). This may well be due to the exclusion from our study 
of patients who had significant renal disease (Table 1). In 
the only previous report that examined the relation between 
autonomic function and diastolic performance (7), no re-
lation was found with beat to beat variability, a test of 
autonomic function thought to involve a reflex arc utilizing 
predominantly parasympathetic pathways (20). 
There is ample experimental evidence to predict that 
alterations in sympathetic nervous activity would alter di-
astolic filling. Parmley and Sonnenblick (29) noted that 
isoproterenol increased relaxation rates in isolated cat pap-
illary muscles. Mitchell et al. (30) demonstrated that during 
pacing-induced tachycardia in dogs, stellate ganglion stim-
ulation at a fixed heart rate resulted in the earlier onset of 
ventricular relaxation, allowing a larger interval for com-
plete relaxation of the ventricle to occur. Diastolic relaxation 
is known to be an energy-dependent process requiring the 
utilization of adenosine triphosphate (ATP) to sequester cal-
cium in the sarcoplasmic reticulum (31). Catecholamines 
facilitate calcium uptake by the sarcoplasmic reticulum, ex-
erting a relaxing effect on the myocardium (32). Depletion 
of myocardial catecholamines is known to occur in patients 
with heart failure (33), and it has been suggested that cate-
cholamine depletion may contribute to defective ventricular 
relaxation in these patients (31). Myocardial catecholamine 
depletion has been reported in diabetic patients without 
congestive heart failure (34), and abnormalities in sympa-
thetic nervous system function may result in altered diastolic 
filling in these patients. 
In our study, plasma catecholamine levels in the supine 
and upright positions were lower in the six subjects with 
abnormal diastolic filling than in the other subjects. Al-
though plasma catecholamine levels may not directly rep-
resent cardiac catecholamine metabolism, they are thought 
to reflect the degree of sympathetic neuronal function (35). 
Furthermore, the strongest correlation between the individ-
ual tests of cardiac autonomic function and diastolic filling 
was with the systolic blood pressure response to standing, 
the only index in the autonomic screening panel utilizing 
a reflex arc involving predominantly sympathetic path-
ways (20). 
Implications. Our findings confirm that abnormalities 
in diastolic filling occur among diabetic patients without 
overt evidence of heart disease, even when systolic function 
is preserved, particularly in those with cardiac autonomic 
neuropathy. Autonomic innervation to the heart may affect 
left ventricular diastolic filling, and sympathetic nervous 
system function may be especially important for normal 
diastolic filling. Longitudinal follow-up to determine whether 
the preclinical abnormalities in diastolic filling observed in 
these patients progress to the clinical syndrome of conges-
JACC Vol 7. No 6 
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tive heart failure will be necessary, and further investigation 
of the role of the autonomic nervous system in this condition 
is warranted. 
We thank Martha Funnell, RN, MS for performing the autonomiC screen-
ing, Lucy Wu-Connolly for technical assistance and Steven Schmaltz, MPH 
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for secretanal support m preparing this manuscript and Mary Harper for 
editorial skills and proofreadmg 
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